More
    Guided Solutions - Connecting Talent With Innovation/div>

    May Health gains CE mark for infertility treatment

    France-based May Health has secured a European CE mark for its Anavi system to address infertility in women with polycystic ovary syndrome (PCOS). The system...

    Vesalio secures FDA clearance for enVast clot retriever

    The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for its commercial launch in the...

    Nephrodite’s continuous dialysis implant wins FDA breakthrough device designation

    The FDA has granted Breakthrough Device Designation to Nephrodite’s Holly implantable continuous dialysis system. In an exclusive interview ahead of the official announcement, Nephrodite co-founder...

    Neurovalens receives FDA approval for weight management device

    Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for...

    FDA clears HeartBeam’s at-home arrhythmia assessment tool

    HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for...

    Resmed wins FDA clearance for AI-enabled personalized CPAP therapy device

    Resmed announced that it received FDA clearance for its Smart Comfort personalized therapy offering. San Diego–based Resmed calls Smart Comfort (which was submitted to the...

    Cardiawave secures CE mark for ultrasound aortic stenosis therapy

    French MedTech Cardiawave has gained an EU CE mark for its non-invasive ultrasound therapy (NIUT) Valvosoft, marking the first device of its kind available...

    Atraverse wins FDA clearance for left heart access device

    Atraverse Medical announced that it received FDA clearance for its fully integrated Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device....

    FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer

    Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug Administration (FDA). Vanquish is a transurethral, ultrasound...

    Latest articles